SGMO Q1 2026 Earnings Gene Therapy Focus Drives Stock Higher Despite Deep EPS Miss BC Q1 2026 Earnings EPS Smashes Estimates by 5476 Stock Climbs TXRH Q1 2026 Earnings EPS Beats Estimates by 10 Stock Rises 26 AEMD Q1 2026 Earnings Narrower Slight Loss Surprise Supports Share Recovery Innate Pharma IPHA Q1 2026 Earnings Deep EPS Miss Weighs on Shares as Pipeline Progress Remains in Focus SUNE Q2 2024 Earnings NarrowerThanExpected Loss Amid Ongoing Restructuring